Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drugs modulating endothelial function after transplantation.

Thomas Nickel1, Christoph L Schlichting, Michael Weis

  • 1Medizinische Klinik und Poliklinik I, University Hospital Munich-Grosshadern, Ludwig-Maximilians University of Munich, Germany.

Transplantation
|July 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences.

Transplantation·2023
Same author

Correction: Catalytic antibodies in arrhythmogenic cardiomyopathy patients cleave desmoglein 2 and N-cadherin and impair cardiomyocyte cohesion.

Cellular and molecular life sciences : CMLS·2023
Same author

Catalytic antibodies in arrhythmogenic cardiomyopathy patients cleave desmoglein 2 and N-cadherin and impair cardiomyocyte cohesion.

Cellular and molecular life sciences : CMLS·2023
Same author

Cardiac structure and function in response to a multi-stage marathon over 4486 km.

European journal of preventive cardiology·2021
Same author

Considerations for Adapting Pre-existing Mechanistic Quantitative Systems Pharmacology Models for New Research Contexts.

Frontiers in pharmacology·2019
Same author

Impact of the gut microbiome in cardiovascular and autoimmune diseases.

Clinical science (London, England : 1979)·2018
Same journal

Hepatic Congestion-linked Intrahepatic Biliary Strictures After Living Donor Liver Transplantation.

Transplantation·2026
Same journal

Filtered or Fried? Rethinking Intraoperative Cell Salvage in Liver Transplantation.

Transplantation·2026
Same journal

Simultaneous Liver-kidney Versus Liver Transplantation Categorized by Pretransplant eGFR: Impact of the 2017 OPTN Policy.

Transplantation·2026
Same journal

Preformed Anti-DQ Alpha Donor-specific Antibodies and the Risk of Antibody-mediated Rejection After Kidney Transplantation.

Transplantation·2026
Same journal

People in Transplantation: Professor Nadey Hakim, MD, PhD, FRCS, FRCSGlas (Hon), FACS, President-Elect of The Transplantation Society.

Transplantation·2026
Same journal

IL-1 Receptor Blockade Modulates Inflammation During Sequential Perfusion in Ex Vivo Porcine Kidneys.

Transplantation·2026
See all related articles

Protecting endothelial cells is crucial for transplant success. Certain immunosuppressants harm these cells, but cardiovascular agents and antiproliferative drugs may offer protection against graft vasculopathy.

Area of Science:

  • Transplantation immunology
  • Vascular biology
  • Immunopharmacology

Background:

  • Endothelial cells are critical for transplant outcomes.
  • Transplant procedures and immunosuppressants can damage endothelium, initiating inflammation and graft vasculopathy.
  • Common immunosuppressants like glucocorticoids and cyclosporine induce endothelial dysfunction.

Purpose of the Study:

  • To review evidence on protecting endothelial cells in transplant recipients.
  • To highlight the role of endothelial cell dysfunction in graft vasculopathy and rejection.
  • To explore potential protective strategies for endothelial cells.

Main Methods:

  • Review of existing literature on endothelial cell function in transplantation.
  • Analysis of the effects of various immunosuppressive and cardiovascular agents on endothelial cells.

Related Experiment Videos

  • Examination of antiproliferative agents' impact on endothelial cell proliferation and migration.

    • Main Results:

    • Glucocorticoids and cyclosporine impair endothelial function; tacrolimus's effects are under investigation.
    • Antiproliferative agents demonstrate protective effects by inhibiting endothelial cell proliferation and migration.
    • Cardiovascular agents (statins, ACE inhibitors, CCBs), immunoregulatory drugs, and dietary compounds show promise in improving endothelial function.

    Conclusions:

    • Endothelial cell dysfunction is a treatable factor in graft vasculopathy and rejection.
    • Antiproliferative agents offer direct protection to endothelial cells.
    • Targeting endothelial function with specific agents presents a viable strategy to improve transplant outcomes.